Metronomic Chemotherapy with Vinorelbine Produces Clinical Benefit and Low Toxicity in Frail Elderly Patients Affected by Advanced Non-Small Cell Lung Cancer

about

Metronomic Chemotherapy with Vinorelbine Produces Clinical Benefit and Low Toxicity in Frail Elderly Patients Affected by Advanced Non-Small Cell Lung Cancer

Item

http://www.wikidata.org/entity/Q58700430

description

article

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Metronomic Chemotherapy with V ...... ced Non-Small Cell Lung Cancer

@en

Metronomic Chemotherapy with V ...... ced Non-Small Cell Lung Cancer

@nl

type

Item

label

Metronomic Chemotherapy with V ...... ced Non-Small Cell Lung Cancer

@en

Metronomic Chemotherapy with V ...... ced Non-Small Cell Lung Cancer

@nl

prefLabel

Metronomic Chemotherapy with V ...... ced Non-Small Cell Lung Cancer

@en

Metronomic Chemotherapy with V ...... ced Non-Small Cell Lung Cancer

@nl

P1476

Metronomic Chemotherapy with V ...... ced Non-Small Cell Lung Cancer

@en

P2093

Alberto Ricci

http://www.w3.org/2001/XMLSchema#string

Alessio Grieco

http://www.w3.org/2001/XMLSchema#string

Bruno Sposato

http://www.w3.org/2001/XMLSchema#string

Chiara Fiorentino

http://www.w3.org/2001/XMLSchema#string

Pierdonato Bruno

http://www.w3.org/2001/XMLSchema#string

P2860

Chemotherapy for advanced non-small cell lung cancer in the elderly population

Chemotherapy and supportive care versus supportive care alone for advanced non-small cell lung cancer

Global trends of lung cancer mortality and smoking prevalence

Impact of smoking on lung cancer treatment effectiveness: a review.

Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update

Metronomic oral vinorelbine as first-line treatment in elderly patients with advanced non-small cell lung cancer: results of a phase II trial (MOVE trial)

A phase Ia/Ib clinical trial of metronomic chemotherapy based on a mathematical model of oral vinorelbine in metastatic non-small cell lung cancer and malignant pleural mesothelioma: rationale and study protocol.

Oral versus intravenous vinorelbine: clinical safety profile.

Metronomic chemotherapy: changing the paradigm that more is better.

Non-small cell lung cancer in the elderly: defining treatment options.

P304

6278403

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2018/6278403

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

2018

http://www.w3.org/2001/XMLSchema#string

P50

Aldo Pezzuto

Michela D'Ascanio

Rita Mancini

P577

2018-08-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30225260

http://www.w3.org/2001/XMLSchema#string

P921

chemotherapy

P932

6129793

http://www.w3.org/2001/XMLSchema#string